1 – 50 of 223
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Repairing the Parkinson Brain
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis : A Nested Case-Control Study with Matched Cases and Controls
(
- Contribution to journal › Article
- 2020
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
- 2018
-
Mark
The vermiform appendix impacts the risk of developing Parkinson’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines
(
- Contribution to journal › Article
- 2016
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
-
Mark
Identification of multiple QTLs linked to neuropathology in the engrailed-1 heterozygous mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeability.
(
- Contribution to journal › Article
-
Mark
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.
2016) In Proceedings of the National Academy of Sciences of the United States of America 113(23). p.6544-6549(
- Contribution to journal › Article
- 2015
-
Mark
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis.
(
- Contribution to journal › Scientific review
-
Mark
Acceleration of α-synuclein aggregation by exosomes
(
- Contribution to journal › Article
-
Mark
A cell culture model for monitoring α-synuclein cell-to-cell transfer.
(
- Contribution to journal › Article
-
Mark
The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1.
(
- Contribution to journal › Article
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Is Exenatide the Next Big Thing in Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Adipocytes derived from PA6 cells reliably promote the differentiation of dopaminergic neurons from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Review: The future of cell therapies and brain repair: Parkinson's disease leads the way.
(
- Contribution to journal › Scientific review
-
Mark
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro.
(
- Contribution to journal › Article
-
Mark
Alpha-synuclein transfers from neurons to oligodendrocytes.
(
- Contribution to journal › Article
-
Mark
Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
The role of Galectin-3 in α-synuclein-induced microglial activation
(
- Contribution to journal › Scientific review
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
- 2013
-
Mark
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
(
- Contribution to journal › Scientific review
-
Mark
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
(
- Contribution to journal › Article
-
Mark
A new approach to disease-modifying drug trials in Parkinson's disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mind the gut: secretion of alpha-synuclein by enteric neurons
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Nonsteroidal Selective Androgen Receptor Modulators and Selective Estrogen Receptor β Agonists Moderate Cognitive Deficits and Amyloid-β Levels in a Mouse Model of Alzheimer's Disease.
(
- Contribution to journal › Article
-
Mark
α-Synuclein: The Long Distance Runner.
(
- Contribution to journal › Article
-
Mark
Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice.
(
- Contribution to journal › Article
-
Mark
Inflammation and α-Synuclein's Prion-like Behavior in Parkinson's Disease-Is There a Link?
(
- Contribution to journal › Scientific review
-
Mark
Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
-
Mark
Microchannel Acoustophoresis does not Impact Survival or Function of Microglia, Leukocytes or Tumor Cells.
(
- Contribution to journal › Article
-
Mark
NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Adsorption of α-Synuclein to Supported Lipid Bilayers: Positioning and Role of Electrostatics.
(
- Contribution to journal › Article
-
Mark
Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments
(
- Contribution to journal › Article
- 2012
-
Mark
Neuropathology in transplants in Parkinson's disease: Implications for disease pathogenesis and the future of cell therapy.
(
- Contribution to journal › Article
-
Mark
Can Parkinson's disease pathology be propagated from one neuron to another?
(
- Contribution to journal › Article
-
Mark
Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo.
(
- Contribution to journal › Article
-
Mark
Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease
(
- Contribution to journal › Article
-
Mark
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
2012) In European Journal of Pharmacology(
- Contribution to journal › Article
-
Mark
The adult human brain harbors multipotent perivascular mesenchymal stem cells.
(
- Contribution to journal › Article
-
Mark
Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells
(
- Contribution to journal › Article
- 2011
-
Mark
Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
Journal of Parkinson's Disease Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A deadly spread: cellular mechanisms of α-synuclein transfer.
(
- Contribution to journal › Article
-
Mark
Stage-Specific Modulation of Cortical Neuronal Development by Mmu-miR-134
(
- Contribution to journal › Article
-
Mark
Membrane Interaction of α-Synuclein in Different Aggregation States
(
- Contribution to journal › Article
-
Mark
The executioners sing a new song: killer caspases activate microglia
(
- Contribution to journal › Scientific review